WVSHP Logo Contact Information
News & Events

News from WVSHP

POCT Certificate Program

The University of Charleston School of Pharmacy will host a pharmacist training session on May 11th from 1-5 PM.  The program will provide the “Community Pharmacy-Based Point-of-Care Testing (POCT) Certificate Program” through the NACDS organization.
 
Specifics from NACDS include:
-Practical, hands-on training in point-of-care testing in four (4) disease states
-20 credit hours of ACPE-accredited continuing education
-Unique dual home study and in-person structure
-Access to and training on the interactive, web-based education platform
 
The cost will be:
    $400 for pharmacists
    $300 for UC alumni and preceptors
    $250 for any current UCSOP students
 
Contact Gannett Monk with any questions at gannettmonk@ucwv.edu, or to request the UC alumni/preceptor/student discount code.
 
To sign up, go to:  http://www.ucwv.edu/POCT/ 

 

ASHP and ACPE revised guidelines ASHP and the Accreditation Council for Pharmacy Education (ACPE) just released revisions to the Accreditation Standards for Pharmacy Technician Educat (Click for more...)

News from elsewhere...
RCGP plea to avoid no-deal Brexit 6/17/2019 7:23:06 AM A no-deal Brexit should be avoided 'at any cost', according to the College (Click for more...) Greater Manchester joins Cities Changing Diabetes initiative 6/17/2019 7:01:35 AM The city is the second in the UK to join the Novo Nordisk led partnership programme (Click for more...) Amgen unveils five-year survival data for Blincyto 6/17/2019 6:49:04 AM Early achievement of complete molecular remission with Blincyto is linked with prolonged survival, researchers note (Click for more...) AZ' Calquence shows PFS benefit in CLL patients 6/17/2019 6:17:28 AM A new filing for the drug as a treatment for relapsed or refractory chronic lymphocytic leukaemia is expected later this year (Click for more...) GSK, Uni of California pair up to advance genomic research 6/14/2019 5:21:13 AM The LGR will receive up to $67 million in funding over a five-year period. (Click for more...) Outdated technology systems still ‘limiting’ UK patient care 6/14/2019 5:18:28 AM Over a third (36%) of respondents’ staff have asked for faster digital technology systems. (Click for more...) Rituxan hits endpoints in late-stage skin disease trial 6/14/2019 5:06:50 AM The drug demonstrated superiority to current standard-of-care to CellCept. (Click for more...) ABPI publishes new guidelines on pharma working with patients 6/14/2019 4:59:23 AM The sourcebook covers six topics, which were identified as areas where further guidance would be of assistance. (Click for more...) Gilead, AbCellera team up against infectious diseases 6/13/2019 1:04:03 PM AbCellera will receive upfront and research payments and is eligible to receive downstream clinical and commercial milestone payments and royalties. (Click for more...) Pixuvri approved for use in EU 6/13/2019 12:58:23 PM The drug has been granted the conversion of the conditional approval into standard marketing authorisation as a single agent. (Click for more...) AZ’ Farxiga shows 47% reduction in kidney function decline 6/13/2019 12:54:13 PM The SGLT2 inhibitor was evaluated in 17,160 patients with type II diabetes. (Click for more...) Invokana hits endpoints in cardiovascular trial 6/13/2019 12:40:45 PM A sub-group analysis found that the Janssen drug provided consistent CV and renal protection. (Click for more...) Strive for success in the 2019 Medical & Scientific Excellence Awards 6/13/2019 9:10:22 AM This competition aims to honour those with exceptional talent within the medical and scientific industry, by offering a platform for candidates to share best practice and prove they’ve got the skills to be successful. (Click for more...) Boehringer, Lilly present positive Trajenta results at ADA 6/12/2019 10:43:38 AM The study is the only active-comparator cardiovascular outcome trial for a DPP-4 inhibitor. (Click for more...) Cosentyx shows efficacy in key manifestations of psoriatic arthritis 6/12/2019 10:37:42 AM The data will be presented at the Annual European Congress of Rheumatology (EULAR) on 12-15 June in Madrid, Spain. (Click for more...)
 
Copyright© 2019 West Virginia Society of Health System Pharmacists. All rights reserved.

Updating...